News

Australian researchers reported investigating the potential use of CRISPR, the gene-editing technology, to stop SARS-CoV-2 virus transmission in infected human cells.

According to iSTAR Medical, the STAR-V study will investigate the device in 350 patients with primary open angle glaucoma.

Looking for potential substitutes to a frequently overused response.

Alkeus Pharmaceuticals, Inc, announced Thursday that the FDA has granted Breakthrough Therapy Designation (BTS) for ALK-001 (C20-D3-vitamin A) for the treatment of Stargardt disease.

Study highlights extracellular matrix-related proteins expressed in PVR.

A team of investigators has found that the retina could offer signs of possible COVID-19 infection before they appear in other parts of the body.

New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.

Holographic technology offers after-surgery glimpse for surgeons, patients.

Measures of inflammation can predict treatment outcomes for patients.

Usher syndrome 1G protein SANS regulates the splicing of genes, particularly those linked to Usher syndrome, which can lead to early vision loss form RP.

There’s no shortage of diet programs—Paleo, Mediterranean, intermittent fasting—all claiming to be the best option for a healthy life. Research has shown that poor lifestyle choices, including unhealthy diets, contribute to many diseases and that simply adhering to good nutrition can even prevent some health issues.

Pressure-dependent optic nerve disease, retinal disease.

Two trials examine factors affecting the risk of disease.

According to Unity Biotechnology, its trial for the small molecule inhibitor of Bcl-xL found improvement in visual acuity and central subfield thickness observed in diabetic macular edema and wet age-related macular degeneration patients treated with UBX1325.

Clues to diagnosis from patient/family histories, examination techniques.

The company, formerly called BELKIN Laser, announced Thursday that it will begin operating under the new name BELKIN Vision.

Physicians in India have reported 7,200 documented cases of mucormycosis infections in patients with severe COVID-19 infections.

Physicians should hospitalize ON patients to prevent blindness, possible death.

Trial shows treatment has acceptable safety profile, may improve visual function.

ASCRS has issued a statement calling on Aetna to drop a new prior authorization policy it implemented last week that delays cataract surgeries.

Ex vivo experiment identifies potential benefit for supplementary oxygen.

MIGS drainage device offers hope for challenging cases.

Technology enables physicians to provide and receive important information more quickly.

Much of today’s surgical refuse is due to the single use of virtually everything.

The American Medical Association recently announced policies adopted by physician and medical student leaders from all corners of medicine on the final day of the Special Meeting of the AMA House of Delegates.

In an observational study, investigators are looking at the role of antibody secreting plasmablasts and GC B cells induced by the COVID-19 vaccines.

Ophthalmologists seek methods to control postoperative inflammation.